Read a patient’s perspective on living with a rare, life-threatening blood cancer called myelofibrosis and why it’s important to rally the community.

Novartis and Broad Institute researchers explore how gut bacteria contribute to health and disease, beginning with type 1 diabetes.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.

Targeting inflammation to fight cancer is a new approach with a long history.

Marjorie Eiref, Head of Operations for Neuroscience Research at Novartis, describes how her family medical history has impacted her career.

The most lethal strain could be eliminated by 2030, but major hurdles remain.

Explaining Chagas disease through the stories of patients in Bolivia.